Cargando…
Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration
IMPORTANCE: Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness with several intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents available for its management such as aflibercept, bevacizumab, and ranibizumab. However, direct comparisons between the...
Autores principales: | Eng, Victor A., Rayess, Nadim, Nguyen, Huy V., Leng, Theodore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200004/ https://www.ncbi.nlm.nih.gov/pubmed/32369500 http://dx.doi.org/10.1371/journal.pone.0232353 |
Ejemplares similares
-
Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
por: Chujo, Shinichiro, et al.
Publicado: (2023) -
Progression of cRORA (Complete RPE and Outer Retinal Atrophy) in Dry Age-Related Macular Degeneration Measured Using SD-OCT
por: Shmueli, Or, et al.
Publicado: (2022) -
Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
por: Savastano, Maria C., et al.
Publicado: (2020) -
A rabbit model for outer retinal atrophy caused by surgical RPE removal
por: Al-Nawaiseh, Sami, et al.
Publicado: (2023) -
Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections
por: Resch, Miklós D., et al.
Publicado: (2022)